BraininHand: Psychological and Quality of Life Impact of Brain in Hand

Sponsor
Cornwall Partnership NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT05468541
Collaborator
braininhand.co.uk (Other)
101
1
8
12.6

Study Details

Study Description

Brief Summary

A prospective cohort mixed study using both qualitative and quantitative elements. The quantitative component will involve tracking outcomes at baseline and at twelve weeks, using Health of the Nation Outcome Scale for People with a Learning Disability (for quality of life) and Hospital Anxiety and Depression Rating Scale (for anxiety and depression). The qualitative study will involve semi structured interviews with end users to understand usage and acceptability of Brain in Hand app with the added impact of the pandemic.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The Brain in Hand App (BiH) has been awarded a Small Business Research Initiatives competitive grant to develop and test new technologies for the NHS https://braininhand.co.uk/news/brain-in-hand-wins-sbri-healthcare-award/ .

    A cohort study is needed to robustly test the BiH technology to evaluate the influence, understand its capabilities, users' experiences, and the effect of clinical impact by looking to align or use the NICE Evidence Framework for Health Digital Technologies, to reference the strengths, weakness, and limitations of BiH specifically around psychological wellbeing and by extension, quality of life. This is the purpose of the study.

    There are more than 700,000 autistic people in the United Kingdom. Autism research has focused on causes of autism and largely missed opportunities to discover what helps autistic people. Research highlights that autistic people experience poor mental and physical health, which go unrecognised. Autistic people have very high rates of comorbid physical disabilities as well as mental health conditions that are impacted bilaterally by the social environment. ASD is unique to the person, so person centred support is needed, and a digital solution may offer the best solution in terms of privacy and cost.

    NHS England recently reported autistic people have high levels of unmet needs and existing health and social services do not usually cater for this complex group, to deliver person centred support. BiH has developed remote person-centred support with self-management tools with 24/7 helpline that encompasses a wraparound healthcare service. This has recently acquired a further interesting dimension as remote interventions have facilitated enhanced accessibility to healthcare during the pandemic.

    The study participants will complete two questionnaires: The self-reporting Hospital Anxiety and Depression Scale and the quality of life, Health of the Nation Scale for people with Learning Disabilities. The questionnaires will gather baseline data and then three months later the same questionnaires will be repeated to understand change. Semi-structured questions will be utilised on a randomly selected sample from the main cohort to gain a user's experience of clinical need and safety.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    101 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Psychological and Quality of Life Impact of Brain in Hand
    Actual Study Start Date :
    Jul 30, 2021
    Actual Primary Completion Date :
    Dec 31, 2021
    Actual Study Completion Date :
    Mar 31, 2022

    Outcome Measures

    Primary Outcome Measures

    1. What is the impact of BiH on quality of life over a three-month period? [3 months]

      The Health of the Nation Outcome Scales for People with Learning Disabilities is measured on a five-point scale (0-4) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared

    2. What is the impact of BiH on the participant's mental health? [3 months]

      Hospital Anxiety and Depression Scale is measured on a four-point scale (0-3) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared

    3. Level of acceptability (drop-out rates) [3 months]

      Drop out rates will be recorded

    4. Discover the participant's experience of using BiH App to measure outcomes of reliance on their care support [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    5. Understand how BiH impacts on coping skills [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    6. To gain understanding of how BIH has impacted on the autistic person's ability to manage challenging social situations [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    7. Does BiH App help autistic people feel safe? [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    8. Does the BiH help autistic people feel more independent? [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    9. Can access 24/7 telephone support help autistic people feel self-empowered to manage their anxiety? [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    10. To gain an understanding of how BiH Traffic Light system helps a person manage their anxiety, independence and support their coping skills [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    11. Does the participant believe remote support has improved their access to healthcare during the pandemic? [3 months]

      Short semi structured interviews with ten end users to understand usage and acceptability

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. All who have been diagnosed with Autism Spectrum Disorder (ASD) as per DSM-5 criteria level (1) or post screening by health professional such as a GP and on the confirmatory diagnostic pathway.

    2. Age ranges from 19 to 80.

    3. Participant has been screened by the Columbia Suicide Rating Scale as not having risk concerns of suicide.

    4. Access to smart devices with compatibility to running BiH. The Participant will require a Smart Phone and either a Laptop / Tablet / Note Book.

    5. Has capacity to give informed consent and can give informed consent.

    6. They can understand the BiH information.

    Exclusion Criteria:
    1. Outside of stated age range within the inclusion criteria.

    2. Any acute or chronic condition, particularly neurodevelopmental conditions such as significant intellectual disability, Level 2/3 DSM V ASD.

    3. Diagnosed con-current psychological comorbidity (psychosis, severe depression etc.) that would limit the ability of the participant to take part in the study.

    4. Anyone who declines to give consent or are unable to give informed consent. 5. Anyone who has been screened positive with the (C-SSRS) suicide risk scale.

    5. Not willing to engage with smart device/internet. 7. Insufficient English language to understand and complete questionnaires.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cornwall Partnership NHS Foundation Trust Bodmin Cornwall United Kingdom PL31 2QN

    Sponsors and Collaborators

    • Cornwall Partnership NHS Foundation Trust
    • braininhand.co.uk

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cornwall Partnership NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT05468541
    Other Study ID Numbers:
    • Version 4 25.10.21
    First Posted:
    Jul 21, 2022
    Last Update Posted:
    Jul 21, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jul 21, 2022